Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Advances in Therapy
|
September 30, 2024
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
Xia Li, Yangfeng Ding, Chunlei Zhang, et al.
Biomedical Reports
|
September 8, 2016
Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi
Jianxin Xia, Yanlong Wang, Fuqiu Li, et al.
Animals : an Open Access Journal From MDPI
|
June 12, 2026
Exploring Growth Pattern and Candidate Genes for Chicken Spur
Hong Yuan, Qianhui Liao, Zhuliang Yang, et al.
Scientific Reports
|
April 1, 2025
BMI matters: understanding the link between weight and severe psoriasis
Huiwei Wang, Suchun Hou, Xiaojing Kang, et al.
The Journal of Dermatological Treatment
|
October 1, 2025
Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patients
Zhuhui Qiao, Bao Chai, Yu Chen, et al.
Chinese Medical Journal
|
May 6, 2024
Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China
Yanhua Liu, Zhongrui Xu, Jian Zhou, et al.
Scientific Reports
|
October 29, 2024
A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis
Huiwei Wang, Jialiang Shi, Suchun Hou, et al.
Journal of Medical Microbiology
|
March 23, 2017
Origin and distribution of Sporothrix globosa causing sapronoses in Asia
Tarek A A Moussa, Naif M S Kadasa, Hassan S Al Zahrani, et al.
Allergy
|
October 25, 2024
Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
Chinese Medical Journal
|
July 23, 2023
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
Yan Zhao, Jianzhong Zhang, Bin Yang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Advances in Therapy
|
September 30, 2024
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
Xia Li, Yangfeng Ding, Chunlei Zhang, et al.
Biomedical Reports
|
September 8, 2016
Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi
Jianxin Xia, Yanlong Wang, Fuqiu Li, et al.
Animals : an Open Access Journal From MDPI
|
June 12, 2026
Exploring Growth Pattern and Candidate Genes for Chicken Spur
Hong Yuan, Qianhui Liao, Zhuliang Yang, et al.
Scientific Reports
|
April 1, 2025
BMI matters: understanding the link between weight and severe psoriasis
Huiwei Wang, Suchun Hou, Xiaojing Kang, et al.
The Journal of Dermatological Treatment
|
October 1, 2025
Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patients
Zhuhui Qiao, Bao Chai, Yu Chen, et al.
Chinese Medical Journal
|
May 6, 2024
Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China
Yanhua Liu, Zhongrui Xu, Jian Zhou, et al.
Scientific Reports
|
October 29, 2024
A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis
Huiwei Wang, Jialiang Shi, Suchun Hou, et al.
Journal of Medical Microbiology
|
March 23, 2017
Origin and distribution of Sporothrix globosa causing sapronoses in Asia
Tarek A A Moussa, Naif M S Kadasa, Hassan S Al Zahrani, et al.
Allergy
|
October 25, 2024
Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
Chinese Medical Journal
|
July 23, 2023
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
Yan Zhao, Jianzhong Zhang, Bin Yang, et al.
Page
of 6